Cystic Fibrosis Clinical Trials
California Pacific Adult Cystic Fibrosis Program | Adult Clinical Trials Main Page
Further protocol information can be found on the links below at ClinicalTrials.gov
Active Trials
Title: A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of MP-376 (Levofloxacin Inhalation Solution; Aeroquin™) In Stable Cystic Fibrosis Patients
Description: MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis
Investigator: Ryan Doughtery, MD
Eligibility: Confirmed diagnosis of Cystic Fibrosis with a postive sputum culture for P. Aeruginosa at screening and within the past 12 months
Contact: Jessica Redford, RN, 415-600-1781,
Email: RedforJ@cpmcri.org about Study MPEX-207
- updated December 2011
Back to top